| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 74,18 | 74,32 | 20:29 | |
| 74,14 | 74,34 | 20:28 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 74,18 | 83 | |||
| 74,14 | 848 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/ewl.htm [/URL] | ||||
| 931 | 73,92 | |||
| 50 | 15,600 | |||
| 1.033 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 2.014 | 0,462 | 931 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 26.05.2026 | 17:17:04 | 74,74 | 203 |
| 26.05.2026 | 17:15:25 | 74,74 | 1 |
| 26.05.2026 | 15:45:17 | 74,40 | 9 |
| 26.05.2026 | 15:30:29 | 73,84 | 23 |
| 26.05.2026 | 15:30:04 | 74,00 | 46 |
| 26.05.2026 | 14:08:46 | 74,00 | 13 |
| 26.05.2026 | 14:08:45 | 74,00 | 16 |
| 26.05.2026 | 12:28:47 | 74,62 | 3 |
| 26.05.2026 | 12:28:47 | 74,36 | 4 |
| 26.05.2026 | 12:28:47 | 74,34 | 34 |
| Tagesumsatz Xetra | +0,32 +0,43 % | 10 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.05. | Medtronic study backs Evolut Tavr head-to-head against Edwards Sapien | 7 | MassDevice | ||
| 08.05. | Edwards Lifesciences Appoints Doretta Mistras As Chief Financial Officer | 5 | pulse2.com | ||
| EDWARDS LIFESCIENCES Aktie jetzt für 0€ handeln | |||||
| 06.05. | Edwards Lifesciences Corp - 10-Q, Quarterly Report | 23 | SEC Filings | ||
| 05.05. | Edwards Lifesciences Appoints Theodora Mistras As Chief Financial Officer | 396 | AFX News | WASHINGTON (dpa-AFX) - Edwards Lifesciences Corporation (EW) said that it has appointed Theodora Mistras as chief financial officer effective at the end of May.Mistras will join Edwards from... ► Artikel lesen | |
| 04.05. | Edwards Lifesciences names Doretta Mistras as new CFO | 2 | Investing.com |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 13:36 | TG Therapeutics, Inc.: TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial | GlobeNewswire (Europe) | Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 initiation dosing and a new single infusion on Day 1 only... ► Artikel lesen | |
| 13:10 | Tilray Brands, Inc.: BrewDog Turns This Summer's Global Football Tournament into a Nationwide Celebration of Beer, Bars and Big Match Moments | GlobeNewswire (Europe) | BrewDog Launches Multi-Channel "Underdog" Campaign Across Retail, Bars and Digital Media - Including a Nationwide "Win a Year of Beer" Contest and Destination Match-Day Watch Parties Across the U.K.
ELLON... ► Artikel lesen | |
| 18:14 | Elanco: Monumental Public-Private Initiative Forms to Permanently Close America's Protein Gap | ACCESS Newswire | America's Farmers, Protein Industry, Hunger Advocates Launch $40 Million Initiative to Deliver 3 Billion Protein-Rich Meals Annually NORTHAMPTON, MA / ACCESS Newswire / May 27, 2026 / On the eve of... ► Artikel lesen | |
| 15:02 | Jaguar Health, Inc.: Jaguar Health Compliant with Nasdaq Bid Price Rule | ACCESS Newswire | JAGX's securities continue to be listed and traded on Nasdaq SAN FRANCISCO, CA / ACCESS Newswire / May 27, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that on... ► Artikel lesen | |
| 14:23 | Buy or Goodbye?: Fedex, Dermapharm, Daimler Truck und Volvo - Die Analystenstimmen des Tages | wallstreetONLINE | © Foto: Kevin Wolf - FR33460 APFedex, Dermapharm, Daimler Truck und Volvo: Die wichtigsten Analysten-Updates im Überblick.JPMorgan hebt das Kursziel für Fedex an Die US-Bank JPMorgan hat das Kursziel... ► Artikel lesen |